Glow Blend

GLOW Blend is a three-component research formulation containing 10 mg BPC-157 (C₆₂H₉₈N₁₆O₂₂), 10 mg TB-500—the N-terminally acetylated seven-residue thymosin beta-4 fragment Ac-LKKTETQ—and 50 mg GHK-Cu (C₁₄H₂₄CuN₆O₄). No specific TB-500 counterion or salt form is asserted without lot-specific confirmation. Lot documentation should identify each analyte, chemical form, purity, and measured content before laboratory use.

GHK-Cu is a copper-binding tripeptide studied in fibroblast gene-expression, extracellular-matrix, collagen, and metalloproteinase models. BPC-157 is a distinct 15-residue synthetic peptide investigated in cellular and preclinical signaling models.

TB-500 is not full-length 43-amino-acid thymosin beta-4. It is the acetylated fragment Ac-LKKTETQ. Published analytical work has characterized TB-500 and its metabolites by LC-MS, while fragment-associated actin and cell-migration hypotheses remain separate from evidence generated with full-length thymosin beta-4. Researchers should not treat the two materials as interchangeable.

For laboratory research use only. Not for human or veterinary administration, diagnostic use, or therapeutic procedures.

Blend comparison: See KLOW vs Glow peptide for a component-by-component laboratory research comparison.

Identity and research references

1. PubChem: TB-500 identity, sequence, formula, and molecular weight
2. LC-MS characterization of N-acetylated LKKTETQ (TB-500)
3. Pickart L, et al. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed Research International. 2015;2015:648108.
4. Sikiric P, et al. Focus on BPC 157. Current Pharmaceutical Design. 2010;16(10):1224–1234.